一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Drugs >>article
Drugs

Drugs

IF: 13
Download PDF

Pirfenidone: a review of its use in idiopathic pulmonary fibrosis.

Published:1 February 2015 DOI: 10.1007/s40265-015-0350-9 PMID: 25604027
Esther S Kim, Gillian M Keating

Abstract

Pirfenidone (Esbriet?) is an orally administered, synthetic, pyridone compound that is approved for the treatment of adults with mild to moderate idiopathic pulmonary fibrosis (IPF) in the EU, and for the treatment of IPF in the USA. This article summarizes pharmacological, efficacy and tolerability data relevant to the use of pirfenidone in these indications. In the randomized, double-blind, placebo-controlled, multinational CAPACITY trials in patients with mild to moderate IPF, a significant reduction in the rate of decline in forced vital capacity (FVC) was seen with pirfenidone versus placebo in study 004 but not in study 006. Pirfenidone also reduced the rate of decline in FVC to a significantly greater extent than placebo in the randomized, double-blind, multinational ASCEND trial in this patient population. In addition, pirfenidone showed a significant treatment effect on the 6-min walking test distance and progression-free survival in the ASCEND trial and in a pooled analysis of the CAPACITY trials. Pirfenidone had a manageable tolerability profile in all three studies. Gastrointestinal and skin-related events (e.g. nausea, rash, photosensitivity reaction), which were the most commonly occurring treatment-emergent adverse events, were generally mild to moderate in severity. In addition, a prespecified mortality analysis across all three studies demonstrated a significant reduction in IPF-related and all-cause mortality with pirfenidone. In conclusion, oral pirfenidone is a valuable agent for use in patients with IPF.

Substances (1)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Pirfenidone 53179-13-8 C12H11NO 681 suppliers $5.00-$1430.00

Similar articles

IF:13

Fenofibrate: a review of its use in dyslipidaemia.

Drugs Kate McKeage, Gillian M Keating,etc Published: 1 October 2011
IF:4.7

Minoxidil and its use in hair disorders: a review.

Drug Design, Development and Therapy Poonkiat Suchonwanit,?Sasima Thammarucha,etc Published: 9 August 2019
辽宁省| SHOW| 临城县| 奇台县| 天台县| 肃宁县| 吉林市| 绩溪县| 恩平市| 山阴县| 壤塘县| 抚远县| 玉溪市| 芜湖县| 阜康市| 巫溪县| 英超| 天门市| 肃北| 南平市| 西畴县| 玉龙| 迁西县| 平度市| 富顺县| 呼图壁县| 于都县| 岳西县| 青冈县| 石台县| 绥阳县| 济源市| 达拉特旗| 濮阳市| 依安县| 凤台县| 武山县| 从江县| 广东省| 偏关县| 巫溪县|